Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study).

[1]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[2]  S. de Servi,et al.  Current management of unprotected left main coronary artery disease: run-in survey of the RITMO (Registro Italiano sul Trattamento del tronco coMune non protettO) study. , 2009, International journal of cardiology.

[3]  Young-Hak Kim,et al.  Stents versus coronary-artery bypass grafting for left main coronary artery disease. , 2008, The New England journal of medicine.

[4]  P. Teirstein,et al.  A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. , 2008, American heart journal.

[5]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[6]  A. Colombo,et al.  Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent. , 2007, American heart journal.

[7]  S. Markwell,et al.  Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents. , 2007, Journal of the American College of Cardiology.

[8]  P. Teirstein,et al.  Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. , 2006, Journal of the American College of Cardiology.

[9]  C. Di Mario,et al.  Results and Long-Term Predictors of Adverse Clinical Events After Elective Percutaneous Interventions on Unprotected Left Main Coronary Artery , 2002, Circulation.